![James Manuso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Manuso
Direktor/Vorstandsmitglied bei
OPUS GENETICS, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
James S.
J.
Manuso founded ZyStor Therapeutics, Inc. in 2004, PrimeTech Partners in 1998, where he worked as General Partner from 1998 to 2002, Galenica Pharmaceuticals, Inc. in 2001, where he worked as Chairman, President & Chief Executive Officer from 2001 to 2003, and various other companies.
Dr. Manuso also currently works at Talfinium Investments, Inc., as Chairman & Chief Executive Officer from 2014, TuHURA Biosciences, Inc., as Chairman from 2024, KineMed, Inc., as Director from 2001, and various other companies.
Dr. Manuso also formerly worked at RespireRx Pharmaceuticals, Inc., as Vice Chairman, President & Chief Executive Officer from 2015 to 2018, SuperGen, Inc., as Chairman, President & Chief Executive Officer from 2003 to 2011, Astex Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2011 to 2013, and various other companies.
Dr. Manuso received his doctorate degree from The New School, undergraduate degree from New York University, and Masters Business Admin degree from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPUS GENETICS, INC. 0.39% | 20.04.2026 | 317’318 ( 0.39% ) | 1 Mio $ | 31.05.2026 |
-.--% | 30.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von James Manuso
| Unternehmen | Position | Beginn |
|---|---|---|
| KINEMED INC | Direktor/Vorstandsmitglied | 01.03.2001 |
| OPUS GENETICS, INC. | Direktor/Vorstandsmitglied | 01.11.2020 |
Laurelside LLC | Vorstandsvorsitzender | 01.01.2018 |
Talfinium Investments, Inc.
 Talfinium Investments, Inc. Talfinium Investments, Inc. is a company based in New York. James S. J. Manuso has been the CEO of the company since 2014. | Vorstandsvorsitzender | 01.01.2014 |
AAON Coil Products, Inc.
 AAON Coil Products, Inc. Industrial MachineryProducer Manufacturing Manufactures and markets air-conditioning and heating equipment | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Manuso
| Unternehmen | Position | Ende |
|---|---|---|
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology Develops biological products | Direktor/Vorstandsmitglied | 01.11.2020 |
| RESPIRERX PHARMACEUTICALS INC. | Vorstandsvorsitzender | 30.09.2018 |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Vorsitzender | 12.02.2014 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Vorstandsvorsitzender | 01.10.2013 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James Manuso
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
RespireRx Pharmaceuticals, Inc.
 RespireRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that discovers and develops drug therapies for the treatment of sleep apnea, respiratory depression & other brain-mediated breathing disorders | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals Engages in manufacturing, marketing and distribution of lumber and wood-based value-added products | Non-Energy Minerals |
TuHURA Biosciences, Inc. (Old)
 TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Merrion Pharmaceuticals Plc
 Merrion Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The Equitable Cos., Inc.
 The Equitable Cos., Inc. Life/Health InsuranceFinance Markets life, property, and casualty insurance also conducts asset management services | Finance |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Eurogen Ltd
 Eurogen Ltd Packaged SoftwareTechnology Services Designs software | Technology Services |
Galenica Pharmaceuticals, Inc.
 Galenica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines | Health Technology |
The New School
 The New School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supratek Pharma, Inc.
 Supratek Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and related oncology therapeutic products | Health Technology |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
ZyStor Therapeutics, Inc.
 ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops innovative therapeutics | Health Technology |
Montigen Pharmaceuticals, Inc.
 Montigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products used for the treatment of cancer | Health Technology |
The Channel Group
 The Channel Group Investment ManagersFinance The Channel Group focuses on the global life sciences industry | Finance |
AAON Coil Products, Inc.
AAON Coil Products, Inc. Industrial MachineryProducer Manufacturing Manufactures and markets air-conditioning and heating equipment | Producer Manufacturing |
PrimeTech Partners | |
Manuso Alexander & Associates, Inc. | |
Symbiontics, Inc. | |
Leukemia & Lymphoma Society Greater San Francisco Bay Area | |
HC Wainwright & Co. LLC
 HC Wainwright & Co. LLC Investment Banks/BrokersFinance Provides investment banking, financial advisory, securities sales, trading and research services | Finance |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talfinium Investments, Inc.
Talfinium Investments, Inc. Talfinium Investments, Inc. is a company based in New York. James S. J. Manuso has been the CEO of the company since 2014. | |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology Develops biological products | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Laurelside LLC |
